A computationally designed H5 antigen shows immunological breadth of coverage and protects against drifting avian strains.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
17 04 2019
Historique:
received: 05 10 2018
revised: 05 03 2019
accepted: 11 03 2019
pubmed: 25 3 2019
medline: 15 8 2020
entrez: 26 3 2019
Statut: ppublish

Résumé

Since the first identification of the H5N1 Goose/Guangdong lineage in 1996, this highly pathogenic avian influenza virus has spread worldwide, becoming endemic in domestic poultry. Sporadic transmission to humans has raised concerns of a potential pandemic and underscores the need for a broad cross-protective influenza vaccine. Here, we tested our previously described methodology, termed Computationally Optimized Broadly Reactive Antigen (COBRA), to generate a novel hemagglutinin (HA) gene, termed COBRA-2, that was based on H5 HA sequences from 2005 to 2006. The COBRA-2 HA virus-like particle (VLP) vaccines were used to vaccinate chickens and the immune responses were compared to responses elicited by VLP's expressing HA from A/whooper swan/Mongolia/244/2005 (WS/05), a representative 2005 vaccine virus from clade 2.2. To support this evaluation a hemagglutination inhibition (HAI) breadth panel was developed consisting of phylogenetically and antigenically diverse H5 strains in circulation from 2005 to 2006, as well as recent drift variants (2008 - 2014). We found that the COBRA-2 VLP vaccines elicited robust HAI titers against this entire breadth panel, whereas the VLP vaccine based upon the recommended WS/05 HA only elicited HAI responses against a subset of strains. Furthermore, while all vaccines protected chickens against challenge with the WS/05 virus, only the human COBRA-2 VLP vaccinated birds were protected (80%) against a recent drifted clade 2.3.2.1B, A/duck/Vietnam/NCVD-672/2011 (VN/11) virus. This is the first report to demonstrate seroprotective antibody responses against genetically diverse clades and sub-clades of H5 viruses and protective efficacy against a recent drifted variant using a globular head based design strategy.

Identifiants

pubmed: 30905528
pii: S0264-410X(19)30336-6
doi: 10.1016/j.vaccine.2019.03.018
pii:
doi:

Substances chimiques

Antigens, Viral 0
Hemagglutinin Glycoproteins, Influenza Virus 0
Influenza Vaccines 0
Vaccines, Virus-Like Particle 0
hemagglutinin, avian influenza A virus 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

2369-2376

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Ted M Ross (TM)

University of Georgia, Center for Vaccines and Immunology, Department of Infectious Diseases, Athens, GA 30602, USA.

Joshua DiNapoli (J)

Sanofi-Pasteur, 38 Sidney Street, Cambridge, MA 02139, USA.

Maryann Giel-Moloney (M)

Sanofi-Pasteur, 38 Sidney Street, Cambridge, MA 02139, USA. Electronic address: Maryann.Giel-Moloney@sanofi.com.

Chalise E Bloom (CE)

University of Georgia, Center for Vaccines and Immunology, Department of Infectious Diseases, Athens, GA 30602, USA.

Kateri Bertran (K)

Exotic and Emerging Avian Viral Diseases Research Unit, Southeast Poultry Research Laboratory, U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, Athens, GA 30602, USA.

Charles Balzli (C)

Exotic and Emerging Avian Viral Diseases Research Unit, Southeast Poultry Research Laboratory, U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, Athens, GA 30602, USA.

Tod Strugnell (T)

Sanofi-Pasteur, 38 Sidney Street, Cambridge, MA 02139, USA.

Mariana Sá E Silva (M)

Boehringer lngelheim, R&D, Athens, GA 30601, USA.

Teshome Mebatsion (T)

Boehringer lngelheim, R&D, Athens, GA 30601, USA.

Michel Bublot (M)

Boehringer lngelheim, S.A.S., R&D, 69007 Lyon, France.

David E Swayne (DE)

Exotic and Emerging Avian Viral Diseases Research Unit, Southeast Poultry Research Laboratory, U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, Athens, GA 30602, USA.

Harry Kleanthous (H)

Sanofi-Pasteur, 38 Sidney Street, Cambridge, MA 02139, USA.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH